Reports for APOTEX INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

250 (7%)

Anticipated shortage:

3 (0%)

Avoided shortage:

11 (0%)

Resolved:

3299 (93%)

3563

Discontinuation Reports

To be discontinued:

24 (7%)

Discontinued:

342 (93%)

Reversed:

0 (0%)

366

143 (4%)

32 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VARENICLINE 0.5MG 1MG KIT TABLET Resolved 2020-09-02 2020-09-14 123589
APO-VARENICLINE 1MG TABLET Resolved 2021-05-07 2025-01-31 138992
APO-VARENICLINE 1MG TABLET Resolved 2024-08-09 2024-08-23 234996
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2019-07-02 86347
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2022-05-16 86341
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-07-17 2020-07-10 89554
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-07-17 2019-11-25 89557
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-05-31 2019-05-31 50971
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2020-05-08 2021-03-09 114327
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2017-05-16 2018-03-08 10442
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-11-20 2019-11-25 99320
APO-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Actual shortage 2023-06-09 2023-08-18 194581
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Actual shortage 2023-06-23 2023-09-01 196306
APO-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Resolved 2022-09-01 2022-09-16 168356
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2022-09-01 2022-11-20 168353
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-09 2023-01-13 177618
APO-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Actual shortage 2022-07-29 2023-09-01 165727
APO-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Actual shortage 2022-12-16 2023-08-18 178766
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2020-01-22 2020-09-14 103926
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-04-10 2018-11-03 45353
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO PEN VK Discontinued 2019-03-08 2019-03-08 78141
APO PEN VK Discontinued 2019-03-08 2019-03-08 78144
APO PREDNISONE TAB 1MG USP 1MG TABLET Discontinued 2017-03-13 2017-03-13 1056
APO PREDNISONE TAB 5MG 5MG TABLET Discontinued 2018-09-08 2018-12-28 60699
APO TRIAZIDE 50MG 25MG TABLET Discontinued 2018-09-08 2019-02-13 60837
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 150MG 300MG TABLET Discontinued 2022-12-12 2022-12-12 177953
APO-ACEBUTOLOL 400MG TABLET Discontinued 2017-03-31 2018-02-05 4965
APO-ACETAMINOPHEN CAPLETS 500MG 500MG TABLET Discontinued 2018-09-07 2018-09-08 60157
APO-ALENDRONATE 5MG TABLET Discontinued 2019-01-03 2019-12-21 71023
APO-ALENDRONATE 10MG TABLET To be discontinued 2018-09-07 2019-12-20 60163
APO-ALENDRONATE 10MG TABLET To be discontinued 2019-01-03 2019-12-20 71026
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83971
APO-ALMOTRIPTAN Discontinued 2019-05-13 2019-05-13 83976
APO-AMITRIPTYLINE 75MG TABLET To be discontinued 2025-01-10 2025-01-10 247472
APO-AMITRIPTYLINE 25MG TABLET Discontinued 2025-01-10 2025-01-11 247466
APO-AMITRIPTYLINE 50MG TABLET To be discontinued 2019-01-04 2021-06-05 71354
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2025-01-10 2025-01-11 247462
APO-AMITRIPTYLINE 50MG TABLET To be discontinued 2025-01-10 2025-01-27 247469
APO-AMITRIPTYLINE 25MG TABLET Discontinued 2019-01-04 2019-02-13 71351
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2019-01-04 2019-01-04 71348